Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort

Christian R Kahrs, Katerina Chuda, German Tapia, Lars C Stene, Karl Mårild, Trond Rasmussen, Kjersti S Rønningen, Knut E A Lundin, Lenka Kramna, Ondrej Cinek, Ketil Størdal, Christian R Kahrs, Katerina Chuda, German Tapia, Lars C Stene, Karl Mårild, Trond Rasmussen, Kjersti S Rønningen, Knut E A Lundin, Lenka Kramna, Ondrej Cinek, Ketil Størdal

Abstract

Objective: To determine whether infection with human enterovirus or adenovirus, both common intestinal viruses, predicts development of coeliac disease.

Design: Case-control study nested within Norwegian birth cohort recruited between 2001 and 2007 and followed to September 2016.

Setting: Norwegian population.

Participants: Children carrying the HLA genotype DR4-DQ8/DR3-DQ2 conferring increased risk of coeliac disease.

Exposures: Enterovirus and adenovirus detected using real time polymerase chain reaction in monthly stool samples from age 3 to 36 months.

Main outcome measure: Coeliac disease diagnosed according to standard criteria. Coeliac disease antibodies were tested in blood samples taken at age 3, 6, 9, and 12 months and then annually. Adjusted odds ratios from mixed effects logistic regression model were used to assess the relation between viral infections before development of coeliac disease antibodies and coeliac disease.

Results: Among 220 children, and after a mean of 9.9 (SD 1.6) years, 25 children were diagnosed as having coeliac disease after screening and were matched to two controls each. Enterovirus was found in 370 (17%) of 2135 samples and was significantly more frequent in samples collected before development of coeliac disease antibodies in cases than in controls (adjusted odds ratio 1.49, 95% confidence interval 1.07 to 2.06; P=0.02). The association was restricted to infections after introduction of gluten. High quantity samples (>100 000 copies/μL) (adjusted odds ratio 2.11, 1.24 to 3.60; P=0.01) and long lasting infections (>2 months) (2.16, 1.16 to 4.04; P=0.02) gave higher risk estimates. Both the commonly detected enterovirus species Enterovirus A and Enterovirus B were significantly associated with coeliac disease. The association was not found for infections during or after development of coeliac disease antibodies. Adenovirus was not associated with coeliac disease.

Conclusions: In this longitudinal study, a higher frequency of enterovirus, but not adenovirus, during early childhood was associated with later coeliac disease. The finding adds new information on the role of viral infections in the aetiology of coeliac disease.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work other than that described above; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Fig 1
Fig 1
Enrolment of study sample. “Invited” children are those who were still actively participating (delivering samples, questionnaires) at start of coeliac disease sub-study and were invited to participate; “participated” are those who consented to participate and were screened for coeliac disease antibodies. *Two cases were excluded from analyses, one owing to missing stool samples and one owing to incorrect use of diagnostic criteria. †Children with positive coeliac disease antibodies at first screening test but for whom follow-up did not confirm coeliac disease diagnosis (n=10) were excluded from further analyses; control children with high antibody titres (>10 times cut-off) (n=2) in old samples but with normal values at screening were excluded and replaced by new controls selected using same matching criteria. ‡One matched control was excluded from analysis owing to missing stool samples
Fig 2
Fig 2
Timeline of study
Fig 3
Fig 3
Development of coeliac disease antibodies. Figure illustrating definition of before, during, and after development of coeliac disease antibodies. Dots represent faecal samples. Primary analysis included only stool samples collected up to age at last antibody negative blood sample for cases and corresponding age for matched controls. Pre-planned sub-analyses explored same association for stool samples collected during development of coeliac disease antibodies (between last negative and first antibody positive blood sample) and samples collected after first antibody positive blood sample

References

    1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43. 10.1056/NEJMra071600
    1. Romanos J, Rosén A, Kumar V, et al. PreventCD Group Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014;63:415-22. 10.1136/gutjnl-2012-304110
    1. Mårild K, Vistnes M, Tapia G, et al. Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease. J Allergy Clin Immunol 2017;139:1696-8. 10.1016/j.jaci.2016.10.016
    1. Liu E, Lee HS, Aronsson CA, et al. TEDDY Study Group Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014;371:42-9. 10.1056/NEJMoa1313977
    1. Agardh D, Lee HS, Kurppa K, et al. TEDDY Study Group Clinical features of celiac disease: a prospective birth cohort. Pediatrics 2015;135:627-34. 10.1542/peds.2014-3675
    1. Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011;29:493-525. 10.1146/annurev-immunol-040210-092915
    1. Mårild K, Kahrs CR, Tapia G, Stene LC, Størdal K. Infections and risk of celiac disease in childhood: a prospective nationwide cohort study. Am J Gastroenterol 2015;110:1475-84. 10.1038/ajg.2015.287
    1. Kemppainen KM, Lynch KF, Liu E, et al. TEDDY Study Group Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life. Clin Gastroenterol Hepatol 2017;15:694-702.e5. 10.1016/j.cgh.2016.10.033
    1. Bouziat R, Hinterleitner R, Brown JJ, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 2017;356:44-50. 10.1126/science.aah5298
    1. Webb A, Starr M. Acute gastroenteritis in children. Aust Fam Physician 2005;34:227-31.
    1. Schumann M, Siegmund B, Schulzke JD, Fromm M. Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol 2017;3:150-62. 10.1016/j.jcmgh.2016.12.006
    1. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40. 10.1111/j.1572-0241.2006.00741.x
    1. Kagnoff MF, Paterson YJ, Kumar PJ, et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995-1001. 10.1136/gut.28.8.995
    1. Mahon J, Blair GE, Wood GM, Scott BB, Losowsky MS, Howdle PD. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut 1991;32:1114-6. 10.1136/gut.32.10.1114
    1. Mercalli A, Lampasona V, Klingel K, et al. No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia 2012;55:2479-88. 10.1007/s00125-012-2591-4
    1. Stene LC, Witsø E, Torjesen PA, et al. Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 2007;29:44-51. 10.1016/j.jaut.2007.04.003
    1. Cinek O, Witsø E, Jeansson S, et al. Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol 2006;35:33-40. 10.1016/j.jcv.2005.03.007
    1. Husby S, Koletzko S, Korponay-Szabó IR, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-60. 10.1097/MPG.0b013e31821a23d0
    1. Bürgin-Wolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991;66:941-7. 10.1136/adc.66.8.941
    1. Bürgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002;37:685-91. 10.1080/00365520212496
    1. Arguelles-Grande C, Norman GL, Bhagat G, Green PH. Hemolysis interferes with the detection of anti-tissue transglutaminase antibodies in celiac disease. Clin Chem 2010;56:1034-6. 10.1373/clinchem.2009.141242
    1. Myléus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009;49:170-6. 10.1097/MPG.0b013e31818c52cc
    1. Honkanen H, Oikarinen S, Pakkanen O, et al. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol 2013;56:348-53. 10.1016/j.jcv.2012.11.018
    1. Claas EC, Schilham MW, de Brouwer CS, et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005;43:1738-44. 10.1128/JCM.43.4.1738-1744.2005
    1. Cinek O, Kramna L, Mazankova K, et al. Virus genotyping by massive parallel amplicon sequencing: adenovirus and enterovirus in the Norwegian MIDIA study. J Med Virol 2018;10: [Epub ahead of print]. 10.1002/jmv.25361.
    1. Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011;34:151-5. 10.2337/dc10-1413
    1. Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. Publisher Correction: The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018;16:391. 10.1038/s41579-018-0022-3
    1. Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, eds. Fields Virology. 7th ed Lippincott Williams &Wilkins, 2007: 839-94.
    1. Witsø E, Palacios G, Cinek O, et al. High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J Clin Microbiol 2006;44:4095-100. 10.1128/JCM.00653-06
    1. Viskari H, Oikarinen S, Hoppu S, et al. Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study. Diabetologia 2018;61:203-9. 10.1007/s00125-017-4410-4
    1. Norwegian Institute of Public Health. Vaksinasjonsveilederen for helsepersonell (information about the norwegian vaccine program). 2017 [cited 6 February 2018]. .
    1. Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009;23:597-608. 10.1111/j.1365-3016.2009.01062.x
    1. Witsø E, Cinek O, Aldrin M, et al. Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study. Int J Epidemiol 2010;39:459-68. 10.1093/ije/dyp333
    1. Oikarinen M, Tauriainen S, Oikarinen S, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 2012;61:687-91. 10.2337/db11-1157
    1. Honkanen H, Oikarinen S, Nurminen N, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 2017;60:424-31. 10.1007/s00125-016-4177-z
    1. Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 2015;64:1682-7. 10.2337/db14-1370
    1. Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011;34:151-5. 10.2337/dc10-1413
    1. Kagnoff MF, Austin RK, Hubert JJ, Bernardin JE, Kasarda DD. Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984;160:1544-57. 10.1084/jem.160.5.1544
    1. Lähdeaho ML, Parkkonen P, Reunala T, Mäki M, Lehtinen M. Antibodies to E1b protein-derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol 1993;69:300-5. 10.1006/clin.1993.1184
    1. Lawler M, Humphries P, O’Farrelly C, et al. Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum. Gut 1994;35:1226-32. 10.1136/gut.35.9.1226
    1. Schumann M, Siegmund B, Schulzke JD, Fromm M. Celiac disease: role of the epithelial barrier. Cell Mol Gastroenterol Hepatol 2017;3:150-62. 10.1016/j.jcmgh.2016.12.006
    1. Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013;13:294-302. 10.1038/nri3407
    1. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-5. 10.1126/science.1071059
    1. Stone VM, Hankaniemi MM, Svedin E, et al. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 2018;61:476-81. 10.1007/s00125-017-4492-z

Source: PubMed

3
Prenumerera